Montelukast Sodium Tablet, Chewable
Product Images NDC 71205-128

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 71205-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure_01 (Montelukast Fig1)

Figure_01 (Montelukast Fig1)
The text is describing a graph or chart depicting the change in height (in centimeters) over weeks on a treatment (Ti-o-a-Montslukast sodium che, 4-4 = Beclomelhasone 336 meg., and aTaE Biacebs (ne2h)). However, the standard errors of the treatment group means are too small to be visible on the plot.*
FDA Label Image

Figure_2 (Montelukast Fig2)

FDA Label Image

Structure (Montelukast Str)

FDA Label Image

71205-128-90 (Montelukast 5mg90)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.